News

Selective Insurance Group's Earnings Anticipation and Insights

Selective Insurance Group's Earnings Anticipation and Insights

Understanding Selective Insurance Group's Upcoming Earnings

Selective Insurance Group (NASDAQ: SIGI) is set to announce its quarterly earnings soon, and investors are eagerly awaiting the news. With predictions circulating among analysts, it’s essential for stakeholders to stay informed about what could affect the company's stock performance.

Analyst Expectations and Earnings Predictions

For the upcoming earnings report, analysts have estimated an earnings per share (EPS) of approximately $1.93. This figure forms a baseline for measuring the company's performance relative to expectations.

Insights into Earnings Guidance

The anticipated announcement holds considerable weight, as investors are keen to know whether Selective Insurance Group will surpass these estimates. The guidance offered will also play a crucial role as it significantly influences stock price movements.

A Glimpse into Earnings History

A look back at the company's recent earnings history reveals that last quarter, Selective Insurance Group reported an EPS that fell short by $0.22. This unexpected result caused a noticeable 17.04% drop in share price the following day, underscoring the impact that earnings reports can have.

Performance Metrics in Context

Reviewing the past few quarters provides additional insight into how shares of Selective Insurance Group have reacted:

Quarter Q2 2025 Q1 2025 Q4 2024 Q3 2024
EPS Estimate 1.53 1.86 1.99 1.65
EPS Actual 1.31 1.76 1.62 1.40
Price Change % -17.00 -2.00 -13.00 -4.00

Stock Performance Overview

As of the latest trading session, shares of Selective Insurance Group were priced at $83.60, reflecting an 11.72% decline over the past year. This downward trend may weigh heavily on long-term shareholders as they approach this significant earnings release.

What Investors Should Monitor

With earnings reports being significant indicators of a company's health, investors are advised to monitor not only the EPS figures but also the broader context provided by the company’s management in guidance statements.

Frequently Asked Questions

What is Selective Insurance Group's expected EPS?

The expected earnings per share (EPS) for Selective Insurance Group is $1.93 for the upcoming quarter.

How did Selective Insurance Group perform last quarter?

Last quarter, the company posted an EPS below expectations, missing by $0.22 and leading to a significant share price drop.

What should investors look for in the earnings announcement?

Investors should focus on the actual EPS compared to estimates and any guidance provided by the management.

How has Selective Insurance Group's stock performed over the last year?

Over the last year, the stock has experienced a decline of approximately 11.72%.

Where can I track Selective Insurance Group's earnings release?

Investors can track all earnings releases for Selective Insurance Group through their earnings calendar on finance websites.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 22

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 20

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 23

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 24

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 13

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 24

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 20

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 17

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 18

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 17

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading

Top 5 Most Recently Viewed Articles

Taitron's Strategic Shift: Nasdaq Delisting and Financial Update

Updated Category News Views 251

Overview of Taitron's Recent Developments Taitron Components Incorporated (NASDAQ: TAIT) recently made headlines by announcing its voluntary delisting from The Nasdaq Stock Market. The company's decision came as it recognized that the cost of maintaining its Nasdaq listing outweighed the benefits for its shareholders. Reasons Behind the Delisting The board concluded that...

Continue Reading
Merck's Two-Drug HIV Treatment Achieves Trial Success

Updated Category News Views 130

Merck's Groundbreaking Two-Drug Regimen for HIV Treatment Recently, Merck & Co Inc (NYSE: MRK) announced promising results from two important Phase 3 clinical trials. This involved their investigational two-drug regimen combining doravirine and islatravir (DOR/ISL) aimed at treating adults living with HIV-1 infection. Key Findings from the Trials The trials were designed...

Continue Reading
Immunic’s Patent Milestone for Vidofludimus Calcium in MS

Updated Category News Views 230

Immunic Achieves Patent Allowance for Vidofludimus Calcium Immunic, Inc. (Nasdaq: IMUX), a leading biotechnology firm, has recently marked a significant milestone by receiving a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application focused on the use of vidofludimus calcium, particularly in the treatment of progressive...

Continue Reading
Creatd, Inc. Advances with OTCQB Approval and Strong Equity

Updated Category News Views 148

Creatd, Inc. Takes a Significant Step with OTCQB Approval Creatd, Inc. (OTC: CRTD) has reached a significant milestone by being approved to trade on the OTCQB Venture Market. This remarkable achievement showcases the company's dedication and progress towards enhancing its market presence. Starting from a pivotal date, Creatd will now be traded on a more recognized...

Continue Reading
KROMATID Unveils Groundbreaking KROMASURE PinPoint Technology

Updated Category News Views 155

KROMATID Launches KROMASURE PinPoint for Enhanced Genomic Analysis With an aim to transform gene therapy development, KROMATID has unveiled its innovative KROMASURE PinPoint system. This next-generation platform revolutionizes transgene integration analysis by providing single-cell resolution that was previously unattainable. Researchers now have the ability to detect...

Continue Reading